RB1 and retinoblastoma: In particular, Rb/p107 double knockout mice and human retinoblastoma patients demonstrate high expression of miR-17-92 clusters in tumor tissues [9] and the inactivation of miR-17-92 by synthetic lethality suppresses the formation of retinoblastoma in mice [10].